Gesellschaft fuer Bioanalytik (GBA)
GermanyWho owns Gesellschaft fuer Bioanalytik (GBA)?
Gesellschaft fuer Bioanalytik (GBA) is a German Healthcare company, currently owned by Quadriga Capital since 2016. It changed hands in 2016, when Adiuva Capital sold.
Hand-verified · updated 2026-07-03
Open JSON · CC-BY
Key facts
Ownership history
2 ownership periods
Adiuva Capital sold Gesellschaft fuer Bioanalytik (GBA) to Quadriga Capital in 2016 after 5 years.
More from Quadriga Capital PE Fund IV
Other portfolio companies in the same fund.
AustriaMore PE-backed in Healthcare
Comparable healthcare deals from other GPs.
US
Questions
Who owns Gesellschaft fuer Bioanalytik (GBA)?
Gesellschaft fuer Bioanalytik (GBA) is currently owned by Quadriga Capital, through Quadriga Capital PE Fund IV, since 2016.
When did Quadriga Capital acquire Gesellschaft fuer Bioanalytik (GBA)?
Quadriga Capital acquired Gesellschaft fuer Bioanalytik (GBA) in 2016.
Who did Gesellschaft fuer Bioanalytik (GBA) sell to?
Adiuva Capital sold Gesellschaft fuer Bioanalytik (GBA) to Quadriga Capital in 2016 (Secondary).
Who has owned Gesellschaft fuer Bioanalytik (GBA) over time?
Gesellschaft fuer Bioanalytik (GBA) has been through 2 private-equity ownership periods: Adiuva Capital · via Adiuva Fund I · 2011–2016 · sold to Quadriga Capital · (Secondary); Quadriga Capital · via Quadriga Capital PE Fund IV · since 2016.